Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of necroptosis-related genes in Parkinson's disease by integrated bioinformatics analysis and experimental validation. | Front Neurosci | 2023 | 37284660 | PubTator, text mining | PubMed |
| MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration. | World J Gastroenterol | 2023 | 37274806 | PubTator, text mining | PubMed |
| Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations. | Nat Commun | 2023 | 37253714 | PubTator, text mining | PubMed |
| Permeability of Metformin across an In Vitro Blood-Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs). | Pharmaceutics | 2023 | 37242599 | PubTator, text mining | PubMed |
| Prior to versus after Metformin Treatment-Effects on Steroid Enzymatic Activities. | Life (Basel) | 2023 | 37240739 | PubTator, text mining | PubMed |
| Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications. | Biology (Basel) | 2023 | 37237539 | PubTator, text mining | PubMed |
| Transporter proteins knowledge graph construction and its application in drug development. | Comput Struct Biotechnol J | 2023 | 37235186 | PubTator, text mining | PubMed |
| Interaction between OCT1 and LPIN1 polymorphisms and response to pioglitazone-metformin tablets in patients with polycystic ovary syndrome. | Chin Med J (Engl) | 2023 | 37232475 | PubTator, text mining | PubMed |
| ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity. | Int J Biol Sci | 2023 | 37215979 | PubTator, text mining | PubMed |
| Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID. | Arch Microbiol | 2023 | 37193831 | PubTator, text mining | PubMed |
| The Onco-Nephrology Field: The Role of Personalized Chemotherapy to Prevent Kidney Damage. | Cancers (Basel) | 2023 | 37190182 | PubTator, text mining | PubMed |
| Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia. | J Am Heart Assoc | 2023 | 37183858 | PubTator, text mining | PubMed |
| The Potential of Single Nucleotide Polymorphisms (SNPs) as Biomarkers and Their Association with the Increased Risk of Coronary Heart Disease: A Systematic Review. | Vasc Health Risk Manag | 2023 | 37179817 | PubTator, text mining | PubMed |
| Molecular Factors and Pathways of Hepatotoxicity Associated with HIV/SARS-CoV-2 Protease Inhibitors. | Int J Mol Sci | 2023 | 37175645 | PubTator, text mining | PubMed |
| Progress in the Quantitative Assessment of Transporter-Mediated Drug-Drug Interactions Using Endogenous Substrates in Clinical Studies. | Drug Metab Dispos | 2023 | 37169512 | PubTator, text mining | PubMed |
| Quaternary Ammonium Compounds: A Chemical Class of Emerging Concern. | Environ Sci Technol | 2023 | 37157132 | PubTator, text mining | PubMed |
| Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations. | Microbiol Spectr | 2023 | 37154682 | PubTator, text mining | PubMed |
| Berberine stimulates lysosomal AMPK independent of PEN2 and maintains cellular AMPK activity through inhibiting the dephosphorylation regulator UHRF1. | Front Pharmacol | 2023 | 37144221 | PubTator, text mining | PubMed |
| In vitro validation of an in vivo phenotyping drug cocktail for major drug transporters in humans. | Eur J Pharm Sci | 2023 | 37142000 | PubTator, text mining | PubMed |
| Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting Polypeptides. | Mol Pharm | 2023 | 37134201 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=16